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June 18, 2013:2487–93rate was twice that observed in the syncope group older than 75
years. This is unexpected too because the long-term (1 year)
prognosis of syncope was found to be related to aging and
comorbidities (3) that are likely to be more frequent in elderly
individuals.
The authors hypothesized that there could have been an
underdiagnosis of unrecognized cardiovascular diseases in syncope
patients 25 to 44 years of age (1).
Here we propose an additional potential explanation. A
preliminary analysis of our STePS (Short-Term Prognosis of
Syncope) (3) database indicated that 1-year syncope recurrence
in working-age (18 to 65 years) patients was as high as 14%.
Significant hazard ratio values of recurrent syncope were also
reported by Ruwald et al. (1) in the 2 groups of syncope subjects
25 to 44 years of age and 45 to 74 years of age. In a setting of
hazardous occupations, syncope recurrence might lead to fatal
work accidents in the group of syncope patients 25 to 44 years
in the present study who, potentially, are active workers.
According to the EUROSTAT Health and Safety at Work in
Europe report (4), most of work fatal accidents are classified as
occurring after “loss of control,” “slipping,” “stumbling,” and
“falling.” All these conditions might be the consequence of an
occult syncope, producing a sudden loss of consciousness and
postural tone.
We wonder whether work accidents, produced by a hidden
syncope recurrence, might play any role in the increased risk of
death found by Ruwald et al. (1) in patients 25 to 44 years of age.
potential answer might be found by matching the present study
ata with occupational accidents recordings. Should this hypoth-
sis be confirmed, an unexplored scenario characterized by remark-
ble social implications could be opened.
Franca Barbic, MD
ranca Dipaola, MD
onica Solbiati, MD
affaello Furlan, MD
Internal Medicine
umanitas Clinical and Research Center
ia Manzoni, 56
0089 Rozzano (MI)
taly
-mail: franca.barbic@humanitas.it
http://dx.doi.org/10.1016/j.jacc.2013.01.086
EFERENCES
1. Ruwald MH, Hansen ML, Lamberts M, et al. Prognosis among
healthy individuals discharged with a primary diagnosis of syncope.
J Am Coll Cardiol 2013;61:325–32.
2. Kapoor W, Snustad D, Peterson J, et al. Syncope in the elderly. Am J
Med 1986;80:419–28.
3. Costantino G, Perego F, Dipaola F, et al., STePS Investigators. Short
and long-term prognosis of syncope, risk factors and role of hospital
admission. Results from the STePS (Short-Term Prognosis of Syncope)
Study. J Am Coll Cardiol 2008;51:276–83.
4. Health and Safety at Work in Europe (1999–2007); EUROSTAT
Statistical Books. Luxembourg: Publications Office of the European
Union; 2010. Available at: http://epp.eurostat.ec.europa.eu/cache/
ITY_OFFPUB/KS-31-09-290/EN/KS-31-09-290-EN.PDF. Ac-
cessed April 2013.Does the Absence of
Comorbidities Really Identify
Low-Risk Syncope Patients?
We read with great interest the paper by Ruwald et al. (1) on the
prognosis among healthy individuals discharged with syncope as
the primary diagnosis. However, we wonder whether the subjects
enrolled in the study can be effectively considered low-risk pa-
tients. Syncope is, most of the time, the first manifestation of
several diseases, some of which are life-threatening, such as
pulmonary embolism (2). In our opinion, the absence of comor-
bidities cannot by itself identify low-risk patients. Indeed, none of
the risk stratification tools for syncope in the emergency depart-
ment (ED), derived in both the short or long term, consider
comorbidities as risk factors, except for cardiac diseases (3). On
the contrary, patient admission to the hospital might be due to the
clinical perception that the patient is not at low risk of adverse
outcomes. During hospital admission, a specific cause of the
syncopal episode is identified in only 30% to 50% of the cases (4,5).
Thus, syncope as primary discharge diagnosis is not necessarily
consistent with the benignity of the clinical presentation.
Moreover, Ruwald et al. (1) observed an increased mortality rate
from syncope after some years, whereas in the first year, data were
inconclusive. If syncope itself were responsible for the increased
mortality, should we not observe such increase in the short term
rather than in the long term when comorbidities (3) seem to play
a more relevant role?
Finally, from our point of view, low-risk patients should be those
without comorbidities but who were also discharged from the ED. It
would be of great interest to re-analyze the data from this point of
view. We think that this analysis could strengthen the study results.
There might be a misprint in Table 3 because the 95%
confidence interval of the point estimate does not include the point
estimate itself.
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Reply
We read with interest the comments on our study (1) by Drs.
Barbic and colleagues and Dr. Bonzi and colleagues.
Dr. Barbic and colleagues got the impression from our paper
that patients 25 to 44 years of age had twice the risk of death than
those older than 75 years of age. This misunderstanding is related
to the hazard ratios mentioned in our study in which the hazard
ratio in the 25 to 44 age group is 2.29, and that for those older than
75 years is 0.98. This is, of course, not the case, and the mentioned
hazard ratios are given for “syncope” compared with “controls” of
the same age group; thus, healthy individuals in the 25 to 44 age
group with syncope have twice the risk of the corresponding
control group without syncope. The relative relationship between
the age groups and the cumulative incidence of death can be seen
in Figure 1, where it is evident that with advanced age, the risk of
death is much higher.
Dr. Barbic and colleagues propose an intriguing hypothesis that
the increased mortality rate in these otherwise healthy patients
with syncope may be caused by work-related accidents. We share
their thoughts and are currently in the process of investigating the
impact of syncope on subsequent accidents, falls, and accidents
involving motor vehicles or large machinery compared with a
matched control population by linking the data provided in this
study with a database containing all data on accidents reported to
the Danish medical system. Hopefully these analyses will provide
data that could be useful for an evidence-based approach to
guidelines on the use of heavy machinery and motorized vehicles
after episodes of syncope.
Dr. Bonzi and colleagues whether our definition of low-risk
patients was appropriate and states that syncope most of the time
is the first manifestation of several diseases in healthy people. We
do not agree that this has been shown before in the referred
literature. We agree that the risk stratification developed is based
on many other factors than comorbidities, but the registries used
for our study do not include this information. Nevertheless, we
find that our study provides valid contemporary data and prognosis
on a very large population of “healthy” patients with syncope. We
also want to emphasize that our definition of healthy individuals
included that they were free of taking medications. Bonzi et al.
state that the results on 1-year mortality were inconclusive, but
we disagree with his interpretation because we clearly demonstrate
that in patients 25 to 74 years of age, “healthy or low-risk” people
with syncope have a significantly increased 1-year mortality rate
compared with matched controls. Finally, Bonzi et al. requests
the data re-analyzed on patients who were only seen in the
emergency department. Our study combined those discharged
from the emergency department with those discharged after
admission. We did, however, also look into those patients who
were discharged from the emergency department only, and the
results were consistent with the overall results. As you noted, there
was a typographical error in the online edition of the paper in theconfidence intervals of the age group younger than 25 years of age;
this was corrected in the print version.
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Reducing Hospitalizations for
Acute Decompensated Heart Failure
The Infusion Room Approach
Collins et al. (1) provide valuable insight into the complex
process and current dilemmas in managing patients who present
to the emergency department (ED) with acute heart failure
(HF). We would like to suggest an additional venue for the
management of this special population: the outpatient infusion
room (OIR), which is very similar to the observation unit
concept proposed by Collins et al. It too has the intended goal
to reduce hospital admissions and 30-day readmissions in a safe
and effective manner. At our institution, we have implemented
a Transitional Care Medicine program that works closely with
cardiologists in the outpatient setting in an effort to meet the
clinical and utilization management challenges that are associ-
ated with HF patients recently discharged from the hospital (2).
As one of the major components of the program, enrolled
patients are educated to contact the transitional care provider
via telephone at the earliest sign of decompensation (weight
gain, edema, shortness of breath, and/or increased fatigue).
Such early communication of symptoms leads to in-person evaluation
by the transitional care provider to help determine the optimal
disposition of the patient. Similar to Collins et al. (1) view-
point, we do not believe that all cases of decompensated HF
require hospital admission. Thus, we use the observation unit
for patients who require a moderate level of escalated care (i.e.,
24 h of intravenous [IV] diuretic therapy) because we recognize
the cost savings to the healthcare system by using this approach
(3). In even milder cases that still require more than traditional
outpatient care, we use the OIR in cases in which patients may
only need 12 h of IV diuretic therapy to relieve dyspnea, for
example. This decision is often guided by the familiarity that
the transitionalist has with the patient and past presentations of
that specific individual. Other institutions have used this
